SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
36.00    0.00 (0.00%)
Bid:
35.50
Ask:
37.80
Spread: 2.30 (6.479%)
Market Cap: £26.43m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Half Year Trading Update

10 Oct 2013 07:00

RNS Number : 1559Q
Carclo plc
10 October 2013
 

10 October 2013

 

Carclo plc

("the group")

 

Half year trading update

 

The board is pleased to announce that the group has traded in line with its expectations for the first half of the financial year.

 

Conductive Inkjet Technology's ("CIT's") new Cambridge facility has been commissioned on schedule and production on its high speed coating line was validated on time. Full scale manufacture of coated film to support Atmel Corporation's ("Atmel's") start-up of the XSense™ program has commenced and CIT revenue in the first half of the financial year was approximately £1.4 million. CIT's shipments will support Atmel's previously announced ramp up of XSense™ which will see its adoption in a number of products launched across a range of tier 1 OEMs during the second half of our financial year. CIT has continued to invest in further technology developments that will support future innovation in the touch screen sector. The board remains confident that this business is on track for significant growth this financial year and into the future.

We are pleased to confirm that in its judgement issued on 7th October 2013, the English High Court has determined that CIT may pursue claims against Uni-Pixel Displays Inc ("Uni-Pixel") in the English courts for breach of confidence and patent entitlement. As a result of this successful decision, Uni-Pixel will be obliged to pay the majority of CIT's costs of this jurisdiction application.

At Carclo Diagnostic Solutions the first phase of our external review of market opportunities has indicated good suitability to a wide range of medical device sectors. The second phase of this review is underway and will assist us in identifying detailed target applications and customer opportunities. In parallel, our technical development has been focussed on performance robustness and test repeatability on both the Micropoc-pro and Micropoc-cat platforms with encouraging initial results.

In Technical Plastics profits will, as expected, be ahead of last year's comparative period. Our US business in particular has traded strongly and is set for further growth. Its capacity expansion project is on track for completion early next year. Our US and Czech businesses are both set to benefit in future years from multiple new business wins.

Reported profits in our LED Technologies division are expected to be in line with the prior year first half helped by good growth in our LED Optics business. With design wins already awarded to Wipac, the division is expected to have a much stronger second half due to the phasing of design, development and tooling projects in our Wipac LED supercar lighting business. Further project wins are anticipated for the second half as manufacturers begin to adopt Wipac's new Hyperlite LED modules.

The group's Precision Engineering division has benefitted from a good first half in its aerospace business and reported profits are expected to be comparable to last year's first half performance.

As usual, due to working days and seasonality, the group will generate a larger proportion of its operating profits in the second half of the year and this will be magnified by the projected increase in CIT coated film sales. The commercialisation of CIT and the growth prospects in Technical Plastics and LED Technologies reflect a very positive outlook for the group and the group's financial position remains strong.

The group will issue its interim results for the period to 30 September 2013 on 19 November 2013.

- ENDS -

 

 

Enquiries:

Carclo plc

01924 268040

Chris Malley, Chief Executive

Robert Brooksbank, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Stephanie Badjonat

 

Notes to editors

Carclo plc is a technology led plastics group. It is a public company whose shares are quoted on the London Stock Exchange.

 

Approximately three fifths of sales are derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, optical and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

 

Approximately two fifths of sales are derived from the supply of specialised precision components to the premium automotive and aerospace industries and LED optics for a wide range of end applications. Carclo is a leader in the development of high power LED lighting for supercars.

 

Carclo's strategy is to develop new technologies and products to drive future growth. Its investment in Conductive Inkjet Technology is at the heart of the newly emerging market for very low cost printed electronics.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFLDIRLAIIV
Date   Source Headline
12th Jul 201811:25 amBUSForm 8.3 - Carclo plc - Ordinary shares
12th Jul 201811:00 amRNSForm 8.3 - Carclo plc
11th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
11th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
10th Jul 20185:50 pmRNSForm 8.3 - [Carclo plc]
10th Jul 20185:27 pmRNSForm 8.3 - [Carclo plc]
10th Jul 20184:10 pmRNSForm 8.3 - [carclo plc]
10th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
10th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
10th Jul 20189:57 amBUSForm 8.3 - Carclo PLC
9th Jul 20183:55 pmRNSForm 8.3 - Carclo plc
9th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
9th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
9th Jul 201810:39 amRNSForm 8.3 - Carclo plc
6th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
6th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
5th Jul 201812:09 pmRNSForm 8 (OPD) - CONSORT MEDICAL PLC
5th Jul 201812:08 pmRNSForm 8 (OPD) - Carclo plc
5th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
4th Jul 20183:04 pmRNSHolding(s) in Company
4th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
4th Jul 201810:26 amRNSForm 8.3 - Carclo plc
3rd Jul 20184:22 pmRNSForm 8.3 - Carclo Plc
3rd Jul 20182:33 pmPRNForm 8.3 - Carclo plc
3rd Jul 20182:26 pmRNSForm 8.3 - [Carclo plc]
3rd Jul 20181:56 pmRNSForm 8.3 - Carclo Plc
3rd Jul 20181:49 pmRNSHolding(s) in Company
3rd Jul 20181:32 pmRNSForm 8.3 - Carclo plc
3rd Jul 20181:00 pmRNSForm 8.3 - Carclo plc
3rd Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
3rd Jul 201811:36 amBUSForm 8.3 - Carclo plc - Ordinary shares
3rd Jul 201811:07 amRNSForm 8.3 - [Carclo plc]
2nd Jul 20181:07 pmRNSResponse to announcement from Consort Medical
2nd Jul 20187:00 amRNSNon-Binding Proposal for Carclo plc
28th Jun 20187:00 amRNSBoard changes
6th Jun 201810:27 amRNSHolding(s) in Company
5th Jun 20187:00 amRNSFinal Results
17th Apr 20187:00 amRNSDirectorate Change
9th Apr 20188:25 amRNSYear End Trading Update
26th Jan 20185:25 pmRNSDirector/PDMR Shareholding
24th Jan 201812:43 pmRNSDirector/PDMR Shareholding (Replacement)
24th Jan 201810:12 amRNSDirector/PDMR Shareholding
17th Jan 201811:27 amRNSHolding(s) in Company
16th Jan 201811:44 amRNSHolding(s) in Company
15th Jan 20187:00 amRNSTrading Update and Board Changes
12th Jan 20182:55 pmRNSHolding(s) in Company
12th Jan 20181:45 pmRNSHolding(s) in Company
10th Jan 20185:01 pmRNSHolding(s) in Company
28th Nov 20175:30 pmRNSHolding(s) in Company
14th Nov 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.